Fatrova FT 160mg/10mg Tablet is a combination medication containing Fenofibrate 160mg and Rosuvastatin 10mg, designed to manage lipid disorders effectively. Fenofibrate primarily works by reducing triglycerides and increasing high-density lipoprotein (HDL) cholesterol, while Rosuvastatin is a statin that lowers low-density lipoprotein (LDL) cholesterol and total cholesterol levels. This dual-action formulation is particularly beneficial for patients with mixed dyslipidemia or those who have not achieved desired lipid control with monotherapy. By targeting multiple pathways in lipid metabolism, Fatrova FT helps reduce the risk of cardiovascular events such as heart attacks and strokes. The tablet is typically prescribed alongside lifestyle modifications including diet, exercise, and weight control. It is important to take the medication as directed by a healthcare professional and to undergo regular monitoring of lipid levels and liver function during treatment. Potential side effects may include muscle pain, gastrointestinal discomfort, and elevated liver enzymes, so any unusual symptoms should be reported promptly. Fatrova FT 160mg/10mg offers a convenient and effective option for comprehensive lipid management in patients requiring combination therapy.